Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.

doi:10.1016/j.jacc.2011.06.027

Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.

Robert A RA Byrne, Adnan A Kastrati, Steffen S Massberg, Anna A Wieczorek, Karl-Ludwig KL Laugwitz, Martin M Hadamitzky, Stefanie S Schulz, Jürgen J Pache, Massimiliano M Fusaro, Jörg J Hausleiter, Albert A Schömig, Julinda J Mehilli, and

J Am Coll Cardiol 58(13):1325-31 (2011) PMID 21920260

The aim of this study was to compare the 3-year efficacy and safety of biodegradable polymer with permanent polymer stents and of everolimus-eluting stents (EES) with sirolimus-eluting stents (SES).

DOI: 10.1016/j.jacc.2011.06.027
Version: za2963e q8za8 q8zbe q8zcc q8zdd q8ze1 q8zf6 q8zg9

Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.

Similar articles you may find interesting…